NSE · LOTUSEYE
Lotus Eye Hospital and Institute Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,355
of 5,096 stocks
▼ 11W
Peak #2,353 · 27 Sep 2026
Lotus Eye Hospital and Institute Limited is a microcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is growing revenue modestly.
Market Cap
238.70 Cr
P/E Ratio
2,869.50
P/B Ratio
3.97
ROE
0.13%
ROCE
1.11%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 17.06 Cr | 13.61 Cr | 13.55 Cr | 13.04 Cr |
| Net Profit | 61.37 L | -31.95 L | -26.07 L | 11.58 L |
| EPS | 0.30 | -0.15 | -0.13 | 0.06 |
| Operating Profit | 1.52 Cr | -14.21 L | -9.02 L | 19.73 L |
Shareholding pattern
Promoter
40.14%
Public
59.86%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 18 Sep 2023 | Dividend | Dividend - Re 0.50 Per Share |
| 18 Sep 2023 | Other | Annual General Meeting |
| 08 Sep 2022 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Sh |
| 08 Sep 2021 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 19 Nov 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.